Biblio

Author Title [ Type

] Year

Filters: First Letter Of Title is S [Clear All Filters]

Journal Article

Corbacioglu S. Sinusoidal Obstruction Syndrome (SOS) and Defibrotide: We Are Not There Yet. Transplant Cell Ther. 2023;29(5):287-288.

Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, et al. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2015.

Wang N, Weng J, Xia J, Zhu Y, Chen Q, Hu D, Zhang X, Sun R, Feng J, Minato N, et al. SIPA1 enhances SMAD2/3 expression to maintain stem cell features in breast cancer cells. Stem Cell Res. 2020;49:102099.

van der Waart AB, Fredrix H, van der Voort R, Schaap N, Hobo W, Dolstra H. siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice. Cancer Immunol Immunother. 2015.

Ahmadi M, Abdolmohamadi-Vahid S, Ghaebi M, Dolati S, Abbaspour-Aghdam S, Danaii S, Berjis K, Madadi-Javid R, Nouri Z, Siahmansouri H, et al. Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial. Int Immunopharmacol. 2019;74:105730.

Chakrbarti A, Jaiswal SRani, Chakrabarti S. Sirolimus as Long-term Graft-versus-host-disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplant Recipients for Non-malignant Disorders is Associated with High Incidence of Acneiform Lesions. Indian J Dermatol. 2015;60(6):588-591.

García E, Buenasmañanas D, Martín C, Rojas R. [Sirolimus associated pneumonitis in a hematopoietic stem cell transplant patient]. Med Clin (Barc). 2015.

Elmariah H, Otoukesh S, Kumar A, Ali H, Arslan S, Shouse G, Pourhassan H, Nishihori T, Faramand R, Mishra A, et al. Sirolimus is an acceptable alternative to tacrolimus for graft-versus-host disease prophylaxis after haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide. Transplant Cell Ther. 2023.

Peccatori J, Forcina A, Clerici D, Crocchiolo R, Vago L, Stanghellini MTL, Noviello M, Messina C, Crotta A, Assanelli A, et al. Sirolimus-based Graft-versus-Host Disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors. Leukemia. 2014.

Mehryab F, Rabbani S, Shekari F, Nazari A, Goshtasbi N, Haeri A. Sirolimus-loaded exosomes as a promising vascular delivery system for the prevention of post-angioplasty restenosis. Drug Deliv Transl Res. 2023.

Skelton RJP, Costa M, Anderson DJ, Bruveris F, Finnin BW, Koutsis K, Arasaratnam D, White AJ, Rafii A, Ng ES, et al. SIRPA, VCAM1 and CD34 identify discrete lineages during early human cardiovascular development. Stem Cell Res. 2014;13(1):172-179.

Zhang T, Zhou Y, Li L, Wang H-H, Ma X-S, Qian W-P, Shen W, Schatten H, Sun Q-Y. SIRT1, 2, 3 protect mouse oocytes from postovulatory aging. Aging (Albany NY). 2016.

Chen Y, Zhou F, Liu H, Li J, Che H, Shen J, Luo E. SIRT1, a promising regulator of bone homeostasis. Life Sci. 2021:119041.

Singh SK, Williams CA, Klarmann K, Burkett SS, Keller JR, Oberdoerffer P. Sirt1 ablation promotes stress-induced loss of epigenetic and genomic hematopoietic stem and progenitor cell maintenance. J Exp Med. 2013.

Li L, Osdal T, Ho Y, Chun S, McDonald T, Agarwal P, Lin A, Chu S, Qi J, Li L, et al. SIRT1 Activation by a c-MYC Oncogenic Network Promotes the Maintenance and Drug Resistance of Human FLT3-ITD Acute Myeloid Leukemia Stem Cells. Cell Stem Cell. 2014;15(4):431-446.

Wu SYing, Liang J, Yang BChen, Leung PSing. SIRT1 Activation Promotes β-cell Regeneration by Activating Endocrine Progenitor Cells via AMPK Signaling-mediated Fatty Acid Oxidation. Stem Cells. 2019.

Lu Y, Ma Z-X, Deng R, Jiang H-T, Chu L, Deng Z-L. The SIRT1 activator SRT2104 promotes BMP9-induced osteogenic and angiogenic differentiation in mesenchymal stem cells. Mech Ageing Dev. 2022:111724.

Zhou Z, Ma D, Li P, Wang P, Liu P, Wei D, Wang J, Qin Z, Fang Q, Wang J. Sirt1 gene confers Adriamycin resistance in DLBCL via activating the PCG-1α mitochondrial metabolic pathway. Aging (Albany NY). 2020;12.

Tian C, Huang R, Xiang M. SIRT1: Harnessing multiple pathways to hinder NAFLD. Pharmacol Res. 2024:107155.

Fang H, Huang Y, Luo Y, Tang J, Yu M, Zhang Y, Zhong M. SIRT1 induces the accumulation of TAMs at colorectal cancer tumor sites via the CXCR4/CXCL12 axis. Cell Immunol. 2021;371:104458.

Lhee SJae, Song E-K, Kim Y-R, Han M-K. SIRT1 Inhibits p53 but not NF-κB Transcriptional Activity during Differentiation of Mouse Embryonic Stem Cells into Embryoid Bodies. Int J Stem Cells. 2012;5(2):125-129.

Wang G, Wang F, Ren J, Qiu Y, Zhang W, Gao S, Yang D, Wang Z, Liang A, Gao Z, et al. SIRT1 Involved in the Regulation of Alternative Splicing Affects the DNA Damage Response in Neural Stem Cells. Cell Physiol Biochem. 2018;48(2):657-669.

Zhou J, Chen H, Wang Q, Chen S, Wang R, Wang Z, Yang C, Chen A, Zhao J, Zhou Z, et al. Sirt1 overexpression improves senescence-associated pulmonary fibrosis induced by vitamin D deficiency through downregulating IL-11 transcription. Aging Cell. 2022:e13680.

Wang H, Hu Z, Wu J, Mei Y, Zhang Q, Zhang H, Miao D, Sun W. Sirt1 Promotes Osteogenic Differentiation and Increases Alveolar Bone Mass via Bmi1 Activation in Mice. J Bone Miner Res. 2019.

Wang P, Yang C, Lu J, Ren Y, Goltzman D, Miao D. Sirt1 protects against intervertebral disc degeneration induced by 1,25-dihydroxyvitamin D insufficiency in mice by inhibiting the NF-κB inflammatory pathway. J Orthop Translat. 2023;40:13-26.

Pages